Sponsor:
Ferring Pharmaceuticals
Code:
NCT05835219
Conditions
Recurrence of Clostridium Difficile Infection
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
REBYOTA™
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Ferring Pharmaceuticals on 2025-02-14.